w*********7
发帖数: 2883 | 1 好消息？
Incyte Corporation (Nasdaq:INCY) today announced that further analyses from
the global, pivotal Phase III clinical program of Jakafi (ruxolitinib or
INC424) are being presented at the 2011 American Society of Hematology (ASH)
Annual Meeting. | b*****h
发帖数: 783 | 2 这些都已经不太重要了，主要看launch后 4Q， 以及接下来的一个Q的销售情况。。
from
ASH)
【在 w*********7 的大作中提到】
: 好消息？
: Incyte Corporation (Nasdaq:INCY) today announced that further analyses from
: the global, pivotal Phase III clinical program of Jakafi (ruxolitinib or
: INC424) are being presented at the 2011 American Society of Hematology (ASH)
: Annual Meeting.
|
|
